Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform

Executive Summary

• Predictmedix AI Inc. announced the launch of its Clinical‑Trial AI Platform, a digital “brain” that uses real‑time adaptive simulation to help pharmaceutical sponsors and CROs model, plan, and adjust clinical trials.
• The platform integrates patient, protocol, site, historical outcome, and cost data to run “what‑if” scenarios, optimize patient‑site matching, and provide cost & ROI modeling with interactive dashboards.
• The company will begin private demonstrations and seek paid pilot programs with sponsors and CROs, positioning the solution in a market projected to exceed $70 billion by 2027.

Key Details

• Platform Purpose: Enable real‑time risk, cost, and enrollment forecasting for clinical trials; reduce trial failures, improve recruitment, and manage budgets.
• Core Features:
• Adaptive Simulation Engine – dynamic “what‑if” scenario analysis updated with live enrollment/site performance data.
• Patient‑Site Optimization – AI‑driven matching to boost recruitment and lower dropout rates.
• Cost & ROI Modeling – proprietary algorithms estimate budget impact alongside projected clinical outcomes.
• Interactive Dashboards – executive and audit views with heatmaps, Sankey plots, and dynamic visualizations.
• Compliance‑Integrated AI – tracks data inputs/simulations for audit and regulatory support.
• Technology Base: Built on patented tech and a high‑fidelity dataset from >500,000 SmartHealth AI Station scans (≈95 % accuracy for vital‑sign detection).
• Market Context: Global clinical‑trials market projected to exceed $70 billion by 2027; growing demand for tools that reduce trial failures and costs.
• Commercial Plan: Private demonstrations underway; company will explore paid pilot programs with pharmaceutical sponsors and CROs as opportunities arise.
• Leadership Quote: “Clinical development urgently needs smarter tools,” said Dr. Rahul Kushwah, COO, emphasizing early identification of challenges to save time and resources.

Notable Quotes

“Our platform is designed to highlight potential clinical trial challenges early, enabling sponsors to make informed adjustments that can help save time and resources and, ultimately, support faster delivery of new therapies.” – Dr. Rahul Kushwah, COO, Predictmedix AI Inc.